These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37535910)

  • 21. Impact of persistent left ventricular regional wall motion abnormalities in childhood cancer survivors after anthracycline therapy: Assessment of global left ventricular myocardial performance by 3D speckle-tracking echocardiography.
    Okuma H; Noto N; Tanikawa S; Kanezawa K; Hirai M; Shimozawa K; Yagasaki H; Shichino H; Takahashi S
    J Cardiol; 2017 Oct; 70(4):396-401. PubMed ID: 28238564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity.
    Mahjoob MP; Sheikholeslami SA; Dadras M; Mansouri H; Haghi M; Naderian M; Sadeghi L; Tabary M; Khaheshi I
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):74-83. PubMed ID: 31513000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
    Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
    Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography.
    Akam-Venkata J; Kadiu G; Galas J; Lipshultz SE; Aggarwal S
    Cardiol Young; 2019 Dec; 29(12):1494-1500. PubMed ID: 31771663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early alteration of left ventricular strain and dys-synchrony index in breast cancer patients undergoing anthracycline therapy using layer-specific strain analysis.
    Li H; Liu C; Zhang G; Wang C; Sun P; Du G; Tian J
    Echocardiography; 2019 Sep; 36(9):1675-1681. PubMed ID: 31454106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic Study of Left Ventricular Pressure-Strain Loop in Evaluating Changes in Left Ventricular Myocardial Work in Breast Cancer Patients After Chemotherapy.
    Tang S; Li H; Song L; Zhou Y
    Int Heart J; 2023; 64(2):203-212. PubMed ID: 37005315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography.
    Song F; Kang Y; Zhang C; Xu Y; Shi J; Guo Y; Zhang Q; Shu X; Cheng L
    Cardiol J; 2017; 24(5):484-494. PubMed ID: 28353310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular endocardial dysfunction in patients with preserved ejection fraction after receiving anthracycline.
    Miyoshi T; Tanaka H; Kaneko A; Tatsumi K; Matsumoto K; Minami H; Kawai H; Hirata K
    Echocardiography; 2014 Aug; 31(7):848-57. PubMed ID: 24354985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
    Tang Q; Jiang Y; Xu Y; Xia H
    J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors.
    Yoldaş T; Yeşil Ş; Karademir S; Şahin G; Arman Örün U; Doğan V; Özgür S
    Cardiol Young; 2019 Jul; 29(7):904-909. PubMed ID: 31218970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
    Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
    Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
    J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of left ventricular function with left atrio-ventricular longitudinal strain in patients with lymphoma underwent anthracycline therapy].
    Li Z; Zhang QL; Shen YH; Shu XH; Cheng LL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1064-1068. PubMed ID: 36418273
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy.
    Anqi Y; Yu Z; Mingjun X; Xiaoli K; Mengmeng L; Fangfang L; Mei Z
    Echocardiography; 2019 Mar; 36(3):495-502. PubMed ID: 30636342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of left ventricular global longitudinal strain assessed by three-dimensional strain imaging in the early detection of anthracyclinemediated cardiotoxicity.
    Mornoş C; Manolis AJ; Cozma D; Kouremenos N; Zacharopoulou I; Ionac A
    Hellenic J Cardiol; 2014; 55(3):235-44. PubMed ID: 24862616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of effects of anthracycline drugs on myocardial function in breast cancer patients by quantitative analysis of layer-specific strain via 2D-STI technology.
    Wu J; Ni Y; Gu C; Gu X; Ji H; Li L; Zhu J; Huang L; Qiao Z
    Am J Transl Res; 2021; 13(3):1184-1196. PubMed ID: 33841648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.